Skip to main content

EIS Portfolio – Current

Current Portfolio

For further information on investing into the Seneca EIS Portfolio Fund please click here.

+ Click for info

23.5 Degrees

- Click to close

23.5 Degrees


23.5 Degrees was launched in 2012 in response to Starbucks’ strategic decision to build its UK business through franchising. Seneca’s funding provides working capital for the roll-out of new stores, enabling 23.5 Degrees to extend its reach into additional regions in the UK and it remains on track to achieve its goal of opening 100 stores by 2020.

23.5 Degrees is run by a highly qualified and competent management team with backgrounds in Starbucks, KFC and Dominos franchises. Starbucks is a world class international brand and the continued growth of branded coffee chains across the UK ensures a good marketplace for 23.5’s expansion.

See website for more details.

+ Click for info

Airnow PLC

- Click to close

Airnow PLC


Following the merge of appScatter and Airpush, Airnow PLC was created in 2019. Airnow is a scalable B2B SaaS platform that allows paying users to distribute their apps to, and manage their apps on, multiple app stores. Additionally, the centralised platform enables app developers and publishers to manage and track performance of their own and competing apps across all of the app stores on the platform.

Read more about Airnow here

+ Click for info

Apex Molecular

- Click to close

Apex Molecular


Apex Molecular, formerly Yprotech, is a specialist chemical technology and process development (PD) company formed in April 2011 and based in Leeds, UK.

Apex Molecular is a synthetic chemistry company providing specialist services for the pharmaceutical, biotechnology (life sciences) and applied chemical sectors. They were established in 2011 and are based in the BioHub at Alderley Park.

Apex Molecular provide fast, reliable, cost effective delivery of chemistry development services for the life sciences and wider chemical sectors. They have an experienced management team with collectively over 65 years experience in the chemical and life sciences sectors. Additionally they have 40+ years chemistry experience across their key staff to ensure they select and apply the correct technology solution for their customer’s needs.

Apex Molecular also have particular expertise in use of precious metal catalysis and catalytic coupling chemistry, either using generic or proprietary homogeneous and supported catalysts. With a background of working with the pharmaceutical industry they are very aware of the need to supply high purity and high quality products.

For more information visit https://apexmolecular.com/ 

+ Click for info

Cloudcall Group plc

- Click to close

Cloudcall Group plc


Cloudcall Group plc is a software company that designs, develops, and operates integrated communications services for customer relationship management systems in North America, the United Kingdom, and Europe. The company provides a suite of cloud-based integrated software and telephony products and services under the CloudCall name. Its CloudCall suite of products allow companies to integrate their telephony systems into their existing CRM software, enabling calls to be made, recorded, logged, and categorized from within the CRM system from which detailed activity reports could be generated. It serves companies within the staffing and recruitment sector. The company was formerly known as Synety Group plc and changed its name to Cloudcall Group plc in May 2016. Cloudcall Group plc was incorporated in 2005 and is headquartered in Leicester.

+ Click for info

Cytox

- Click to close

Cytox


Cytox Ltd is an innovative developer of assays for risk assessment and prediction of dementia.

Cytox is a UK-based company with a unique scientific and proprietary technology platform that is helping to increase the understanding of the biology behind dementia risk. The focus is on the development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Read more about Cytox here

+ Click for info

Equals Group

- Click to close

Equals Group


Equals is a leading payments company offering SMEs a suite of payments products across FX transactions, prepaid card solutions, Faster Payments and accounts into which receipts can be credited and payments made. The Group enables its personal and business customers to make easy, low-cost payments both domestically and in a broad range of currencies, across a range of products, all via one integrated system.

Equals provides money movement services to both business and personal customers through five inter-connected channels: International Payments; Corporate Expenses platform; Bank Accounts; and Travel Money, comprising currency cards and physical currency. The International Payments channel supports wire transfer foreign exchange transactions direct to bank accounts. For corporates, Equals has a market-leading business expenses solution based around its corporate platform and prepaid card. Equals also offers business and retail bank accounts with all the payments functionality offered by banks, namely faster payments, BACs, direct debits, international payments and a debit card. The Travel Money offerings (retail currency card and physical currency) represent cost-effective and secure methods for travelers to spend abroad.

+ Click for info

Evgen Pharma

- Click to close

Evgen Pharma


Evgen is based in Liverpool, at the Liverpool Science Park and was founded in 2007 by Dr Stephen Franklin.

Evgen is a clinical stage drug development company whose lead programmes are in cancer and subarachnoid haemorrhage (a type of stroke). It is also carrying out preclinical work in relapsing remitting multiple sclerosis.

Evgen’s core technology is Sulforadex®, a novel, synthetic and stabilised version of the naturally occurring compound sulforaphane. Sulforaphane is an established anti-cancer agent that benefits from a huge amount of peer-reviewed scientific literature identifying both its anti-cancer and neuroprotective characteristics. However, its commercial development as a potential prescription medicine has been prevented by the instability of the compound. Evgen’s Sulforadex® technology overcomes this problem by creating a stable version of sulforaphane, which can be delivered as a tablet or capsule.

The potential of Sulforadex® has allowed Evgen to attract a highly experienced commercial, scientific and advisory team. The company is led by Chief Executive Dr Stephen Franklin, who has a track record in the commercialisation of intellectual property, and Chairman Barry Clare, the former director of the Boots Company plc and head of its Boots Healthcare International business.

Read more about evgen pharma here

+ Click for info

Fabacus

- Click to close

Fabacus


Fabacus is an independent software company that has developed a complete product lifecycle solution: Xelacore, aimed at bringing transparency to supply chain networks, with an initial focus on resolving the interaction and information flow between global licensors and their licensees.

Currently, there is a fundamentally flawed data capture process between licensors and licensees; and a disconnection from the framework of retail standards that have underpinned and continue to enable the retail value chain. This has resulted in an inability to correctly address known shortcomings in respect to data management and hinder the needed digital transformation of licensors in the digitally evolving retail landscape.

Fabacus’s solution, Xelacore, is a modular, Software as a Service solution with an intuitive interface and proprietary data aggregation and management engine that allows all stakeholders to operate on a single unified and collaborative platform. It bridges the gaps in an inefficient process within the current retail ecosystem by creating authenticated, enriched universal records that unlock opportunities, reduce risk and drive performance for both licensors and licensees.

+ Click for info

Fairway International Travel Ltd

- Click to close

Fairway International Travel Ltd


Fairway International Travel Ltd, formerly Incorporate Travel Management, is a fast growing, full service travel provider headquartered in Manchester.

Fairway Travel provide solutions for all travel needs, saving customers time and the stress of organising corporate and leisure travel. Fairway Travel’s team of experts have a wealth of industry knowledge and always deliver the best in travel management. A professional management service is delivered by experienced travel consultants with the added customer benefits of 24/7 access to a travel information portal.

Read more about Fairway International Travel here

+ Click for info

Gelmetix

- Click to close

Gelmetix


Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.

+ Click for info

LoopUp Group

- Click to close

LoopUp Group


The LoopUp Group is a global software-as-a-service (“SaaS”) provider of conference calling software, allowing users to take part in remote meetings.

Streamlined and intuitive, LoopUp is designed to eliminate common frustrations associated with conference calls to deliver a premium remote meeting experience for mainstream business users along with the quality, security, and reliability expected by global blue-chip companies.

Founded in 2003, the Group is headquartered in the UK and has offices in San Francisco, New York, Boston, Hong Kong and Barbados, employing more than 100 people.

See more at Loopup.com

+ Click for info

Old St Labs

- Click to close

Old St Labs


Old St Labs is a provider of cloud based, supplier collaboration tools for large, blue chip customers, enabling them to manage key supplier relationships and strategic project work. The core product, Vizibl, seeks to make supplier collaboration much more straight forward, with key focus on compliance, savings / efficiency and driving growth across the business.

Vizibl is the only SaaS workspace that supports collaborative supplier relationships, bringing all points of contact together in one place, providing visibility across the company and eliminating duplication of efforts. Vizibl’s real-time reporting speeds up decision making, drawing on and sharing the expertise of the community in the process. The offering taps into a growing trend in supplier collaboration, having moved on from the initial focus on compliance, to an increased emphasis on savings / efficiency, and recent developments highlighting the benefits in terms of wider growth strategy for large customers.

Vizibl provides the infrastructure, governance and reporting capabilities to optimise present supplier performance and acts as a springboard for those collaborative supplier relationships. The product is CRM / ERP agnostic, working alongside all major software providers to ensure the collaboration software is insightful and informative.

+ Click for info

Oncimmune Holdings plc

- Click to close

Oncimmune Holdings plc


Oncimmune is an early cancer detection company, developing and commercialising products to diagnose cancer in the United Kingdom and North American markets. The company engages in the development of an autoantibody based platform to allow cancer detection for a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test, which is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company also develops EarlyCDT-Liver to aid in the detection and confirmation of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes tests for liver cancer. Oncimmune Holdings Plc was incorporated in 2015 and is headquartered in Nottingham, the United Kingdom.

+ Click for info

OptiBiotix Health

- Click to close

OptiBiotix Health


OptiBiotix (AIM:OPTI) was formed in March 2012 to develop compounds which modify the human microbiome – the collective genome of the microbes in the body – to prevent and manage human disease.

The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations which modulate the human microbiome and can be used as food ingredients, supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.

The company has developed a portfolio of intellectual property in and around this field of research, consisting of patents, trademarks and novel microbial strains. Further intellectual property is expected to be developed or acquired as opportunities arise from existing and future research and development.

OptiBiotix has been working with leading international key opinion leaders and entered into a research agreement with the University of Reading on 18 September 2012 to generate novel microbiome modulating compounds using reverse enzyme synthesis. All intellectual property arising from this research is owned by OptiBiotix.

Seneca fully exited the initial OptiBiotix investment in 2018.

Find out more about Optibiotix here

+ Click for info

Polarean Imaging Plc

- Click to close

Polarean Imaging Plc


Polarean Imaging plc is a healthcare technology company which has developed a state of the art proprietary drug-device combination addressing a specific global unmet need in the field of healthcare. The company’s technology has been developed over a number of years and provides a visual representation of ventilation and gas exchange in the lungs. Xenon, when polarised in Polarean’s proprietary drug-device system, permits functional, regional and quantitative imaging of the lungs using MRI, without the risk of exposing patients to ionising radiation. The technology is being used in the field of respiratory disease – both in the understanding and treatment of it.

+ Click for info

Poolbeg Pharma Plc

- Click to close

Poolbeg Pharma Plc


Poolbeg Pharma is a clinical-stage pharmaceutical company focused on the development and commercialisation of therapies to treat and prevent infectious diseases. Headquartered in London, the business is a spin out from Open Orphan Plc and the management team has proven capabilities in identifying, acquiring and accelerating assets through development to commercialisation. It has adopted a capital-light model which enables it to develop multiple products faster and more cost effectively than the traditional biotech model, and the company aspires to become a “one-stop shop” for big pharma to find Phase II ready products for development and commercialisation.

The company’s lead asset is POLB 001, a drug with the potential to treat serious unmet needs in patients suffering from severe influenza.

+ Click for info

Reacta Biotech

- Click to close

Reacta Biotech


​Reacta Biotech develops, manufactures and commercialises oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP). The company was founded in June 2013 by its three founders: Professor Clare Mills, Professor Ashley Woodcock and Peter McPartland.

Read more about Reacta Biotech here

+ Click for info

Redag Crop

- Click to close

Redag Crop


The engine of discovery for the agrochemical industry.

Redag Crop Protection (“Redag”) is a Cheshire based agrochemical discovery business, with particular focus on new fungicides, herbicides, insecticides and nematicides – products which play a vital role in controlling the pests and diseases that threaten our global food supply.

Redag’s novel and broadly validated Redox Switch™ approach allows them to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter, less costly development cycles, bringing rapid innovation to the industry. There is a growing need for new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance.

The crop protection industry typically spends $250m over a 9 year period testing up to 140,000 candidate compounds in order to bring a single new product to market.

The Redox Switch™ platform has allowed Redag to secure novel intellectual property around existing best in class products through preparation of new compounds that are one or more oxidation state removed from the original. This novel chemistry approach has provided the company with fast and efficient access to an extensive pipeline of new candidates across multiple high value applications. The structural similarity of these compounds to parent compounds that are well characterised and understood reduces the overall risk profile for Redag’s candidates. This also reduces development times, redundancy in testing and the cost of the discovery to market cycle. In addition, this similarity to existing product classes means that current manufacturing assets may be used for production, further reducing the cost of market entry.

Find out more information at www.redagcrop.com

+ Click for info

Rockar

- Click to close

Rockar


A revolutionary, simple new way to find and buy a car…

Rockar challenges the traditional car dealership model by allowing the consumer to be empowered. Consumers can buy a new car either online or in store without any interaction with sales people – their interaction is led by the technology platform which is capable of delivering car sales in the home or in store. The in store experience is supported by ‘Car Angels’ with a focus on customer experience rather than the traditional high pressured aggressive sales process which research identifies as the worst part of buying a new car.

Find out more information at www.rockar.com

+ Click for info

SilkFred

- Click to close

SilkFred


SilkFred is a platform for the best independent fashion brands to sell their products online and for shoppers who love cool, unique clothes to discover them.

Read more about SilkFred here

+ Click for info

SkinBioTherapeutics

- Click to close

SkinBioTherapeutics


SkinBioTherapeutics is a life science company focused on skin health. The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin.

SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.

Read more about SkinBio Therapeutics here

+ Click for info

Sorted Group

(previously MPD Group)

- Click to close

Sorted Group

(previously MPD Group)


Sorted Group (previously known as My Parcel Delivery) provide reliable but economical parcel delivery services including domestic, international, economy, drop off, express, weekend and same day across a range of the world’s leading courier companies.

Sorted has commercial arrangements with a number of key courier suppliers and is able to achieve volume pricing discounts for directing sales through these relationships. It allows consumers to gain access to more competitive pricing on courier and parcel deliveries than they would otherwise achieve themselves.

Sorted organise and facilitate the delivery of over one million parcels a year on behalf of 100,000 customers via 14 different couriers to over 200 countries.

Sorted are very proud of their reputation for delivering great service to their customers…their reviews and statistics speak for themselves…

95% – Couriers spot on time; 53% – Typical savings; 98% – Happy customers

Find out more information at sorted.com

+ Click for info

Totally

- Click to close

Totally


Totally plc is focused on the provision of professional health coaching which promotes and facilitates self care. Totally’s services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

Totally currently operates contracts with NHS England and several CCGs across England delivering their Long Term Condition Management and Shared Decision Making Programs. Totally Health is a provider of a range of services to the healthcare sector that supports individuals to better understand their clinical conditions and support them to avoid exacerbations of such conditions and promote self care.

Shared Decision Making and the Management of Long Term Conditions are key strategic areas for the NHS in England. The NHS in England estimates that £7 out of every £10 spent on health and social care is spent looking after people diagnosed with a Long Term Condition.

For more information visit Totallyplc.com

+ Click for info

Transense Technologies Plc

- Click to close

Transense Technologies Plc


Founded in 1991 and listed on the AIM Market (UK AIM:TRT), Transense is a leader in patent-protected, highly specialised sensor systems and enabling technology for use in a variety of diverse high growth markets.

Its Surface Acoustic Wave (SAW) sensors are wireless, battery-less and are used in the real-time measurement of torque, temperature and pressure to improve power, performance and efficiency through condition monitoring and asset/predictive maintenance. This patent-protected technology offers significant advantages over alternative sensors, and is particularly targeted towards the aircraft, specialised automotive, renewable energy and industrial markets.

iTrack technology, used for monitoring the tyre and vehicle performance of heavy-duty off-road vehicles, was licensed to Bridgestone Corporation for a ten-year term commencing in June 2020.

The Transense team is world leading in SAW and delivers great results. It devotes significant energy and resources ensuring the technology remains at the forefront of its field, continually looks for new ideas, simplicity and ease of use.

+ Click for info

Vapour Media

- Click to close

Vapour Media


Vapour Media is a technology company that provides SME resellers with a point of access to highly competent independent, private network infrastructure, a choice of leading network providers, and a scalable platform for growth, backed by comprehensive training and fully managed installation and support.

With more and more solutions now applied as a service, the way Vapour do business is being revolutionised. The Brighouse-based company provides connectivity and access to its own private network and voice services via its next generation VoIP platform.

The SME appetite for infrastructure access is growing fast, but to satisfy it, the reseller community needs both the right products and training in how to use them. Through its partner channel, Vapour provides a network infrastructure that is scalable enough for its clients to deliver services now and in the future.

Read more at VapourMedia.co.uk

+ Click for info

Velocity Composites

- Click to close

Velocity Composites


Velocity Composites PLC (LON:VEL), makes composites that keep the parts of an aeroplane together. Started in 2007 by three engineers who specialise in composites, the company operates out of its headquarters in Burnley and a facility in Fareham. Its clients include multi-national aerospace manufacturers of composite parts and assemblies, who in turn deliver to the world’s leading civil and military aircraft manufacturers.

“Velocity was founded in 2007 based on the simple premise of deploying our industry knowledge and expertise to make the supply chain more efficient and less expensive for our customers within the aerospace composites industry” said Jon Bridges, chief executive officer of Velocity.

Read more at Velocity-Composites.com

+ Click for info

Wejo

- Click to close

Wejo


Wejo are revolutionising the car industry with innovative user-centric B2C solutions developed using a cutting-edge combination of big data, telematics and mobile technology.

User experience is always at the forefront of their own-brand, white label and bespoke app developments. Using rewards-based models and unique journey data capturing technology, Wejo deliver unparalleled business insights for a range of companies and enable them to better connect with their customer base.

Wejo has evolved so it is about more than journey data capturing alone; they’ve expanded their scope to include a trusted driving data exchange platform and are continually seeking valuable and unique solutions for businesses wanting to reach their customers and stand out in the marketplace.

The wejo Group runs three successful brands: wejo Rewards, their rewards and driving app; wejo SDK, their journey data capturing technology; and OEMx, a secure and vast data exchange platform.

Through these brands and solutions, Wejo offer clients and partners creative opportunities to reach their customer and potential customer base alongside delivering invaluable behavioural insights.

Read more about Wejo here

+ Click for info

Yu Group

- Click to close

Yu Group


Yü Group PLC (Yü Energy) is a UK-based independent specialist supplier of gas and electricity. They focus on servicing small and medium-sized businesses across the UK. Yü also offers certain ancillary services. Yü has approximately four sales channels, including Direct sales, through an outbound telesales team; Corporate sales, which focuses on servicing corporates; Broker sales, which focuses on securing contracts through third-party intermediaries, and Renewals, which services existing customers whose initial contracts are due to expire.

Yü Group PLC are a “challenger” energy supplier providing a complete energy solution to commercial customers.

Read more about Yu Group Plc here